The rationale for use of topical corticosteroids in allergic rhinitis

Clinical and Experimental Allergy, Supplement

Volumn 26, Issue 3, 1996, Pages 2-10

  Mygind, N ^a,c   Dahl, R ^b  

^a Rigshospitalet   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c NONE   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYTOKINE; FLUTICASONE;

ALLERGIC RHINITIS; ANTIINFLAMMATORY ACTIVITY; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; HUMAN; MAST CELL; PRIORITY JOURNAL; SNEEZING; T LYMPHOCYTE; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, INTRANASAL; ADMINISTRATION, TOPICAL; ADRENAL CORTEX HORMONES; HUMANS; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL;

EID: 0029992519     PISSN: 09602178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (42)

1. Mygind N. Local effect of intranasal beclomethasone dipropionate aerosol in hay fever. Br Med J 1974; 3:464-6.
2. Fokkens WJ, Vroom TM, Rijntjes E, Mulder PGH. CD1+ HLA-DR-expressing cells, presumably Langerhans cells in the nasal mucosa. Allergy 1989; 44:167-72.
3. Fokkens WJ, Rijntjes E, Vroom TM, Mulder PGH. Fluctuation of the number of CD-1 positive dendritic cells, presumably Langerhans cells, in the nasal mucosa of patients with an isolated grass-pollen allergy before, during and after the grass-pollen season. J Allergy Clin Immunol 1989; 84:39-43.
4. Holm AF, Fokkens WJ, Godthelp T et al. Effect of 3 months' nasal steroid therapy on nasal T cells and Langerhans cells in patients suffering from allergic rhinitis. Allergy 1995; 50:204-9.
5. Henriksen J, Wenzel A. Effect of an intranasally administered corticosteroid (budesonide) on nasal obstruction, mouth breathing, and asthma. Am Rev Respir Dis 1984; 130:1014-8.
6. Aubier M, Levy J, Clerici C, Neukirch F, Herman D. Different effects of nasal and bronchial glucocorticosteroid administration on bronchial hyperresponsiveness in patients with allergic rhinitis. Am Rev Respir Dis 1992; 146:122-6.
7. Winther B, Innes DJ, Mills SE et al. Lymphocyte subsets in normal mucosa of the human nose. Arch Otolaryngol 1987; 113:59-62.
8. Pawankar R, Okuda M. A comparative study of the characteristics of intraepithelial and lamina propria lymphocytes of the human nasal mucosa. Allergy 1993; 48:99-105.
9. Howarth P. The cellular basis for allergic rhinitis. Clin Exp Allergy 1995; 50(suppl 23):6-10.
10. Schleimer RP. Glucocorticosteroids. In: Middleton E, Reed CE, Ellis EF, eds. Allergy: principles and practice. 3rd edn. St Louis: Mosby, 1993:893-925.
11. Varney VA, Jacobson MR, Sudderick RM et al. Immunohistology of the nasal mucosa following allergen-induced rhinitis. Am Rev Respir Dis 1992; 146:170-6.
12. Durham SR, Sun Ying, Varney VA et al. Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and GM-CSF in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia. J Immunol 1992; 148: 2390-4.
13. Calderón MA, Lozewicz S, Prior A et al. Lymphocyte infiltration and thickness of the nasal mucous membrane in perennial and seasonal allergic rhinitis. J Allergy Clin Immunol 1994; 93:635-43.
14. Fokkens WJ, Holm AF, Rijntjes E, Mulder PGH, Vroom TM. Characterization and quantification of cellular infiltrates in nasal mucosa of patients with grass-pollen allergy, non-allergic patients with nasal polyps and controls. Int Arch Allergy Appl Immunol 1995 (in press).
15. Rak S, Jacobson MR, Sudderick RM et al. Influence of prolonged treatment with topical corticosteroid (fluticasone propionate) on early and late phase responses and cellular infiltration in the nasal mucosa after allergen challenge. Clin Exp Allergy 1994; 24:930-9.
16. Masuyama K, Jacobsson MR, Rak S et al. Topical glucocorticosteroid (fluticasone propionate) inhibits cells expressing mRNA for IL-4 in the nasal mucosa in allergen-induced rhinitis. Immunology 1994; 82:192-9.
17. Kanai N, Denburg JA, Evans S et al. Nasal polyp inflammation. Am J Respir Crit Care Med 1994; 150:1094-100.
18. Howarth PH. The airway inflammatory response on allergic asthma and its relationship to clinical disease. Allergy 1995; 50(suppl 22):13-21.
19. Naclerio RM, Baroody FM, Kagey-Sobotka A, Lichtenstein LM. Basophils and eosinophils in allergic rhinitis. J Allergy Clin Immunol 1994; 94:1303-9.
20. Bascom R, Wachs M, Naclerio RM et al. Basophil influx occurs after nasal antigen challenge: effect of topical corticosteroid pretreatment. J Allergy Clin Immunol 1988; 81:580-9.
21. Meltzer EO, Orgel HA, Bronsky EA et al. A dose-ranging study of fluticasone propionate aqueous nasal spray for seasonal allergic rhinitis assessed by symptoms, rhinomanometry, and nasal cytology. J Allergy Clin Immunol 1990; 86:221-30.
22. Okuda M, Sakagushi K, Ohtsuka H. Intranasal beclomethasone: mode of action in nasal allergy. Ann Allergy 1983; 50:116-20.
23. Konno A, Yamakoshi T, Terada N, Fujita Y. Mode of action of a topical steroid on immediate phase reaction after antigen challenge and nonspecific nasal hyperreactivity in nasal allergy. Int Arch Allergy Immunol 1994; 103:79-87.
24. Pipkorn U. Effect of topical glucocorticoid treatment on nasal mucosal mast cells in allergic rhinitis. Allergy 1983; 38:125-9.
25. Pipkorn U, Proud D, Lichtenstein LM et al. Inhibition of mediator release in allergic rhinitis by pretreatment with topical glucocorticosteroids. N Engl J Med 1987; 316:1506-10.
26. Jacobi H, Stahl-Skov P, Reimert CM et al. Histamine and tryptase in nasal lavage fluid following challenge with allergen and methacholine. J Allergy Clin Immunol 1995 (in press).
27. Wang D, Clement P, Smitz J, De Waele M, Derde M-P. Correlations between complaints, inflammatory cells and mediator concentrations in nasal secretions after nasal allergen challenge and during natural allergen exposure. Int Arch Allergy Appl Immunol 1995; 106:278-85.
28. Bisgaard H, Grønborg H, Mygind N et al. Allergen-induced increase of eosinophil cationic protein in nasal lavage fluid: effect of the glucocorticoid budesonide. J Allergy Clin Immunol 1990; 85:891-5.
29. Klementsson H, Svensson C, Andersson M et al. Eosinophils, secretory responsiveness and glucocorticoid-induced effects on the nasal mucosa during a weak pollen season. Clin Exp Allergy 1991; 21:705-10.
30. Lozewicz S, Wang J, Duddie J et al. Topical glucocorticoids inhibit activation by allergen in the upper respiratory tract. J Allergy Clin Immunol 1992; 89:951-7.
31. Venge P, Dahl R. Are blood eosinophil number and activity important for the development of the late asthmatic reaction after allergen challenge? Eur Respir J 1989; 2(suppl 6): 430-43.
32. Farr BM, Gwaltney JM, Hendley JO et al. A randomized controlled trial of glucocorticoid prophylaxic against experimental rhinovirus infection. J Infec Dis 1990; 162: 1173-7.
33. Davies RJ, Devalia JL. Epithelial cell dysfunction in rhinitis. In: Busse WW, Holgate ST, eds. Asthma and rhinitis. Oxford: Blackwell Science Ltd, 1995: 612-24.
34. Persson CGA, Erjefält I, Alkner U et al. Plasma exudation as a first line respiratory mucosal defence. Clin Exp Allergy 1991; 21:17-24.
35. Persson CGA, Greiff L, Andersson M et al. Mucosal exudation of plasma in asthma and rhinitis. In: Busse WW, Holgate ST, eds. Asthma and rhinitis. Oxford: Blackwell Science Ltd, 1995:733-41.
36. Svensson C, Klementsson H, Andersson M et al. Glucocorticoid-induced attenuation of mucosal exudation of fibrinogen and bradykinins in seasonal allergic rhinitis. Allergy 1994; 49:177-83.
37. Connell JT. Quantitative intranasal pollen challenge. III. The priming effect in allergic rhinitis. J Allergy 1969; 43:33-8.
38. Andersson M, Andersson P, Pipkorn U. Topical glucocorticosteroids and allergen-induced increase in nasal reactivity: relationship between treatment time and inhibitory effect. J Allergy Clin Immunol 1988; 82:1019-26.
39. Andersson M, Mygind N. Nasal hyperresponsiveness. In: Busse WW, Holgate ST, eds. Asthma and Rhinitis. Oxford: Blackwell Science Ltd, 1995:1057-66.
40. Lund V. International consensus report on the diagnosis and management of rhinitis. Allergy 1994; 49(suppl 19):1-34.
41. Pipkorn U. Budesonide and nasal allergen challenge testing in man. Allergy 1982; 37:129-34.
42. Grønborg H, Bisgaard H, Rømeling F, Mygind N. Early and late nasal symptom response to allergen challenge. Allergy 1993; 48:87-93.